New research validates a remote olfactory assessment that successfully identifies cognitive impairment and may provide a cost-effective screening tool for preclinical Alzheimer's disease and other neurodegenerative disorders.
Population aging is predicted to be the primary contributor to the estimated 112% surge in global Parkinson's disease cases by 2050, a BMJ study finds.
Study finds mothers with MS have a higher risk of peripartum mental illness, with 50.3% affected in the first postpartum year—emphasizing the need for early intervention.